
The Future of Precision Oncology Is Now in Türkiye with Foundation Medicine Technology
FOCUS CGP is a comprehensive solid tumor panel developed using Foundation Medicine technology.
| Technical Specifications | |
|---|---|
| Method: NGS – Hybrid Capture | Coverage: ~2000x (High Sensitivity) |
Coverage: 335 Genes (>2 Mb)* 321 Genes: All exons 22 Genes: Exons + selected intronic regions 12 Genes: Critical fusion partner introns *Designed to be equivalent in scope to the FoundationOne® CDX test panel. | |
Sample Requirements: FFPE (Paraffin Block) or Surgical Resection / Fine Needle Aspiration (FNA) / Cell Block | Genomic Signatures: TMB, gLOH, MSI, HRDsig (Across all cancer types) |
| Assay Kit: ROCHE AVENIO CGP v2 (CE-IVD approved) | Sequencing System: İlumina NextSeq 550 DX (CE-IVD approved) |
| Bioinformatics System: Foundation Medicine (FMI) | Accreditation: This test is CAP Accredited. |
Other Features:
| |
*Single biomarkers analyzed by IHC and FISH methods can also be integrated into the report as needed.


19 Mayıs Mah. Çoruh Sok. No:32/1 Fulya, Şişli / Istanbul, Turkey
Monday - Friday 09:00 - 18:00 Saturday 09:00 - 14:00